| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 91,6 k € | +9.0% | 84,0 k € | +12.8% | 74,5 k € | -48.7% | 145,3 k € | +773.4% | 16,6 k € | -28.0% | 23,1 k € | +1.1% | 22,9 k € | -27.3% | 31,4 k € | +31.4% | 23,9 k € | +2.7% | 23,3 k € | +28.0% | 18,2 k € | +47.9% | 12,3 k € | +5.8% | 11,6 k € | -39.3% | 19,2 k € | -67.6% | 59,1 k € | +320.4% | 14,1 k € | +80.2% | 7,8 k € | +34.3% | 5,8 k € | +258.8% | -3,7 k € | |
| EBITDA | 76,8 k € | -8.3% | 83,8 k € | +14.3% | 73,3 k € | -48.9% | 143,5 k € | +901.0% | 14,3 k € | -32.2% | 21,1 k € | +3.5% | 20,4 k € | +14.5% | 17,8 k € | -18.8% | 22,0 k € | +14.1% | 19,3 k € | +21.0% | 15,9 k € | +50.9% | 10,5 k € | +16.0% | 9,1 k € | -51.7% | 18,8 k € | -67.5% | 57,9 k € | +327.7% | 13,5 k € | +88.8% | 7,2 k € | +23.4% | 5,8 k € | +251.3% | -3,8 k € | |
| Operating profit | 30,0 k € | -30.6% | 43,3 k € | -36.0% | 67,6 k € | -51.7% | 139,8 k € | +280653.8% | 49,8 € | -99.3% | 6,9 k € | +11.7% | 6,1 k € | +72.9% | 3,5 k € | -53.8% | 7,7 k € | +71.8% | 4,5 k € | +297.9% | 1,1 k € | +126.5% | -4,2 k € | +81.1% | -22,4 k € | -90.5% | -11,8 k € | -142.3% | 27,8 k € | +286.3% | -14,9 k € | -308.5% | 7,2 k € | +23.4% | 5,8 k € | +251.3% | -3,8 k € | |
| Profit/loss | 20,4 k € | -35.0% | 31,4 k € | -30.4% | 45,1 k € | -55.9% | 102,3 k € | +129567.5% | -79,0 € | -101.7% | 4,7 k € | -59.1% | 11,5 k € | +355.3% | 2,5 k € | -47.2% | 4,8 k € | +17.2% | 4,1 k € | +370.7% | 868,3 € | -98.6% | 62,6 k € | +237.5% | -45,5 k € | -294.7% | -11,5 k € | -141.6% | 27,7 k € | +328.7% | -12,1 k € | -184.5% | -4,3 k € | -724.1% | 682,0 € | +110.5% | -6,5 k € | |
| Equity | 298,2 k € | +7.3% | 277,8 k € | +12.7% | 246,4 k € | +22.4% | 201,2 k € | +103.3% | 99,0 k € | -0.1% | 99,1 k € | +5.0% | 94,4 k € | +13.9% | 82,8 k € | +3.2% | 80,3 k € | +6.3% | 75,5 k € | +5.7% | 71,4 k € | +1.2% | 70,6 k € | +783.4% | 8,0 k € | -85.1% | 53,5 k € | -17.7% | 65,0 k € | +74.2% | 37,3 k € | -24.5% | 49,4 k € | -7.9% | 53,7 k € | +1.3% | 53,0 k € | |
| Total assets | 1,4 M € | -1.3% | 1,4 M € | +30.8% | 1,1 M € | +97.9% | 551,3 k € | +34.1% | 411,2 k € | +11.4% | 369,1 k € | -12.4% | 421,3 k € | -1.0% | 425,7 k € | -6.2% | 453,8 k € | -1.5% | 460,6 k € | +0.5% | 458,2 k € | -3.2% | 473,6 k € | +11.5% | 424,9 k € | -5.7% | 450,3 k € | -1.1% | 455,5 k € | +4.5% | 436,0 k € | -0.6% | 438,5 k € | +19.4% | 367,2 k € | +92.2% | 191,1 k € | |
| Cash | 50,9 k € | +112.9% | 23,9 k € | +19.8% | 20,0 k € | -94.8% | 385,2 k € | +4410.8% | 8,5 k € | +2.0% | 8,4 k € | -70.6% | 28,4 k € | +584.2% | 4,2 k € | -3.6% | 4,3 k € | -81.5% | 23,3 k € | +83.2% | 12,7 k € | -5.8% | 13,5 k € | -9.0% | 14,8 k € | -24.1% | 19,5 k € | -26.1% | 26,4 k € | +46.7% | 18,0 k € | -16.9% | 21,7 k € | -49.2% | 42,7 k € | +633.6% | 5,8 k € | |
| Debts | 1,1 M € | -2.8% | 1,1 M € | +37.8% | 808,3 k € | +157.8% | 313,5 k € | +3.5% | 302,8 k € | +16.2% | 260,6 k € | -19.9% | 325,3 k € | -5.1% | 342,8 k € | -7.6% | 371,0 k € | -3.7% | 385,1 k € | -0.4% | 386,8 k € | -4.0% | 403,0 k € | -3.3% | 416,9 k € | +5.1% | 396,9 k € | +1.6% | 390,5 k € | -2.1% | 398,7 k € | +2.5% | 389,1 k € | +24.1% | 313,5 k € | +127.1% | 138,1 k € | |
Public limited company · Fosses-la-Ville · incorporated on 15/07/2008
Public limited company profitable and well capitalised. Cash position rising (+112.9%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
MOENS CONSULTING is a Public limited company incorporated in 2008. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Fosses-la-Ville.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette